Docusign Inc. (NASDAQ:DOCU) Short Interest Update

Docusign Inc. (NASDAQ:DOCU) saw a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 14,053,218 shares, an increase of 58.5% from the January 29th total of 8,866,066 shares. Approximately 7.1% of the shares of the company are short sold. Based on an average daily trading volume, of 5,560,267 shares, the short-interest ratio is currently 2.5 days. Based on an average daily trading volume, of 5,560,267 shares, the short-interest ratio is currently 2.5 days. Approximately 7.1% of the shares of the company are short sold.

Docusign Price Performance

Shares of DOCU stock traded up $0.86 during trading hours on Monday, reaching $45.93. 1,656,519 shares of the company were exchanged, compared to its average volume of 4,888,772. Docusign has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The stock’s fifty day moving average is $56.08 and its two-hundred day moving average is $66.60. The company has a market cap of $9.20 billion, a price-to-earnings ratio of 32.09, a P/E/G ratio of 1.96 and a beta of 1.03.

Insider Activity at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of Docusign stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the sale, the chief executive officer directly owned 142,261 shares of the company’s stock, valued at $9,901,365.60. This trade represents a 15.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,515 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total value of $650,159.95. Following the sale, the chief financial officer owned 118,213 shares in the company, valued at approximately $8,077,494.29. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 78,291 shares of company stock valued at $5,365,134. 1.66% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently made changes to their positions in DOCU. Norges Bank bought a new position in Docusign in the fourth quarter valued at about $186,795,000. Capital World Investors lifted its position in Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after purchasing an additional 1,603,900 shares during the period. Woodline Partners LP boosted its stake in shares of Docusign by 24,412.7% in the 3rd quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock valued at $69,130,000 after purchasing an additional 955,026 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Docusign by 46.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,001,132 shares of the company’s stock worth $205,277,000 after buying an additional 946,512 shares during the period. Finally, Marshall Wace LLP grew its position in shares of Docusign by 1,575.5% during the 4th quarter. Marshall Wace LLP now owns 888,411 shares of the company’s stock worth $60,767,000 after buying an additional 835,388 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have issued reports on DOCU. Cantor Fitzgerald reissued an “outperform” rating on shares of Docusign in a report on Wednesday, December 17th. Wedbush dropped their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. UBS Group reduced their price target on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Royal Bank Of Canada dropped their price objective on shares of Docusign from $95.00 to $70.00 and set a “sector perform” rating for the company in a report on Monday, January 5th. Finally, BTIG Research reduced their target price on Docusign from $88.00 to $70.00 and set a “buy” rating on the stock in a report on Wednesday, February 18th. Five research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to data from MarketBeat, Docusign has a consensus rating of “Hold” and a consensus target price of $78.80.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.